From: PKCα-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1
Group
P-gp
TGF-β1
PKCα
Membrane
Plasma
Carcinoma
35 (83.3%)
34 (80.9%)
25 (59.5%)
22 (52.3%)
Non-cancer
7 (16.7%)*
8 (19.1%)*
2 (4.8%)*
35 (83.3%)*